scispace - formally typeset
Journal ArticleDOI

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura.

Reads0
Chats0
TLDR
A prospective randomized trial comparing plasma exchange with plasma infusion for the treatment of thrombotic throm bocytopenic purpura finds plasma exchange is more effective than plasma infusion.
Abstract
Background. Thrombotic thrombocytopenic purpura is an uncommon disease with a high mortality rate even with current treatment. The cause of the syndrome and its optimal treatment are unknown. Although both plasma exchange and plasma infusion have been useful treatments, it is not clear which is superior. In this report we describe a prospective randomized trial comparing plasma exchange with plasma infusion for the treatment of thrombotic thrombocytopenic purpura. Methods. One hundred two patients with thrombotic thrombocytopenic purpura were randomly assigned to receive either plasma exchange or plasma infusion with fresh-frozen plasma on seven of the first nine days after entry into the trial. The total volume of plasma received by patients undergoing plasma exchange was three times that received by patients undergoing plasma infusion. All the patients also received aspirin and dipyridamole. The outcomes in the two groups were compared at the end of the first treatment cycle (day 9) and after s...

read more

Citations
More filters
Journal ArticleDOI

Antibodies to von willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

TL;DR: Inhibitory antibodies against von Willebrand factor-cleaving protease occur in patients with acute thrombotic throm bocytopenic purpura, suggesting that a deficiency of this protease is likely to have a critical role in the pathogenesis of platelet thromBosis in this disease.
Journal ArticleDOI

Syndromes of Thrombotic Microangiopathy

TL;DR: This review article covers the diverse pathophysiological pathways that can lead to microangiopathic hemolytic anemia and a procoagulant state with or without damage to the kidneys and other organs.
Journal ArticleDOI

Structure of von Willebrand factor cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura

TL;DR: The 4.6-kilobase pair cDNA sequence for VWFCP has been determined and may have functional significance, producing proteins with distinct abilities to interact with cofactors, connective tissue, platelets, and von Willebrand factor.
References
More filters
Journal ArticleDOI

A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship

TL;DR: In this article, a generalization of the Kruskal-Wallis test for testing the equality of K continuous distribution functions when observations are subject to arbitrary right censorship is proposed, where the distribution of the censoring variables is allowed to differ for different populations.
Journal ArticleDOI

Treatment of thrombotic thrombocytopenic purpura with plasma.

TL;DR: Since the pathogenesis of this disease is not understood, treatment has been empirical or with an assumed rationale, among the various modes of therapy tried, four are especially advocated: splenectomy and use of antiplatelet agents, of high doses of glucocorticoids, and of exchange transfusions.
Related Papers (5)